IL17A and cystic fibrosis: Our observations are in concert with reported reduced levels of IL-17A upon treatment with exogenous pentraxin-3 in murine models of chronic P. aeruginosa lung infection (112) and cystic fibrosis (113) and suggest an inverse correlation between pentraxin-3 and IL-17A dependent pathway.